171 related articles for article (PubMed ID: 33580506)
1. GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme.
Hasanpour Segherlou Z; Nouri-Vaskeh M; Noroozi Guilandehi S; Baghbanzadeh A; Zand R; Baradaran B; Zarei M
J Cell Physiol; 2021 Aug; 236(8):5564-5581. PubMed ID: 33580506
[TBL] [Abstract][Full Text] [Related]
2. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
3. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
5. The divergent roles of growth differentiation factor-15 (GDF-15) in benign and malignant skin pathologies.
Ünal B; Alan S; Başsorgun Cİ; Karakaş AA; Elpek GÖ; Çiftçioğlu MA
Arch Dermatol Res; 2015 Sep; 307(7):551-7. PubMed ID: 25690161
[TBL] [Abstract][Full Text] [Related]
6. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
7. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta.
Roy LO; Poirier MB; Fortin D
Invest New Drugs; 2015 Oct; 33(5):1020-31. PubMed ID: 26271735
[TBL] [Abstract][Full Text] [Related]
10. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
[TBL] [Abstract][Full Text] [Related]
11. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma.
Johansson E; Zhai Q; Zeng ZJ; Yoshida T; Funa K
Exp Cell Res; 2016 May; 343(2):118-125. PubMed ID: 27048878
[TBL] [Abstract][Full Text] [Related]
13. The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma.
Shi P; Xu J; Cui H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373484
[TBL] [Abstract][Full Text] [Related]
14. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
15. The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.
Zhu H; Woolfenden S; Bronson RT; Jaffer ZM; Barluenga S; Winssinger N; Rubenstein AE; Chen R; Charest A
Mol Cancer Ther; 2010 Sep; 9(9):2618-26. PubMed ID: 20643786
[TBL] [Abstract][Full Text] [Related]
16. Control of glioma cell migration and invasiveness by GDF-15.
Codó P; Weller M; Kaulich K; Schraivogel D; Silginer M; Reifenberger G; Meister G; Roth P
Oncotarget; 2016 Feb; 7(7):7732-46. PubMed ID: 26741507
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor.
Li S; Guo W; Gao Y; Liu Y
Tumour Biol; 2015 Apr; 36(4):2607-12. PubMed ID: 25431263
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.
Afshari AR; Mollazadeh H; Soukhtanloo M; Hosseini A; Mohtashami E; Jalili-Nik M; Modaresi SMS; Soltani A; Sahebkar A
Mini Rev Med Chem; 2020; 20(18):1879-1899. PubMed ID: 32767939
[TBL] [Abstract][Full Text] [Related]
19. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
20. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
